Arovella Therapeutics (ASX:ALA) Interest Received : A$0.09 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Arovella Therapeutics Interest Received?

Arovella Therapeutics's Interest Received for the six months ended in Dec. 2023 was A$0.08 Mil.

Arovella Therapeutics's Interest Received for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.09 Mil.

Arovella Therapeutics Interest Received Historical Data

The historical data trend for Arovella Therapeutics's Interest Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arovella Therapeutics Interest Received Chart

Arovella Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Received

Get a 7-Day Free Trial

0.03

0.01

0.03

Arovella Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Received	Get a 7-Day Free Trial															-	-	0.01	0.02	0.08

Arovella Therapeutics Interest Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Received represents interest received by the company in the direct cash flow method.

Interest Received for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.09 Mil.

Arovella Therapeutics Interest Received Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's Interest Received provided by GuruFocus.com. Please click on the following links to see related term pages.

Arovella Therapeutics (ASX:ALA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » Interest Received

Comparable Companies

Traded in Other Exchanges

E4NA:Germany

Address

62 Lygon Street, Level 3, Carlton, WA, AUS, 3053

Website

https://www.arovella.com

Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (ASX:ALA) Headlines

No Headlines